1143. Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonatal and Pediatric Participants With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized, Clinical Trial

BACKGROUND: Ceftolozane/tazobactam (C/T) is a cephalosporin–β-lactamase inhibitor combination approved to treat complicated urinary tract infections (cUTI), complicated intra-abdominal infections, and nosocomial pneumonia in adults. Safety and efficacy of C/T in neonatal and pediatric participants w...

Descripción completa

Detalles Bibliográficos
Autores principales: Roilides, Emmanuel, Ashouri, Negar, Bradley, John S, Johnson, Matthew G, Lonchar, Julia, Su, Feng-Hsiu, Huntington, Jennifer A, Popejoy, Myra W, Bensaci, Mekki, De Anda, Carisa S, Rhee, Elizabeth G, Bruno, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643900/
http://dx.doi.org/10.1093/ofid/ofab466.1336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643900/
http://dx.doi.org/10.1093/ofid/ofab466.1336

Ejemplares similares